Phosphofructokinase 1 Glycosylation Regulates Cell Growth and Metabolism
California Institute of Technology · Howard Hughes Medical Institute · +2 more institutions
Abstract
Cancer cells must satisfy the metabolic demands of rapid cell growth within a continually changing microenvironment. We demonstrated that the dynamic posttranslational modification of proteins by O-linked β-N-acetylglucosamine (O-GlcNAcylation) is a key metabolic regulator of glucose metabolism. O-GlcNAcylation was induced at serine 529 of phosphofructokinase 1 (PFK1) in response to hypoxia. Glycosylation inhibited PFK1 activity and redirected glucose flux through the pentose phosphate pathway, thereby conferring a selective growth advantage on cancer cells. Blocking glycosylation of PFK1 at serine 529 reduced cancer cell proliferation in vitro and impaired tumor formation in vivo. These studies reveal a…
Citation impact
- FWCI
- 19.88
- Percentile
- 100%
- References
- 63
Authors
9- WYWen Yi
California Institute of Technology, Howard Hughes Medical Institute
- PMPeter M. Clark
California Institute of Technology, Howard Hughes Medical Institute
- DEDaniel E. Mason
Genomics Institute of the Novartis Research Foundation
- MCMarie C. Keenan
Agios Pharmaceuticals (United States)
- CHCollin Hill
Agios Pharmaceuticals (United States)
Topics & keywords
- Phosphofructokinase
- Serine
- Glycosylation
- Biochemistry
- Glycolysis
- Metabolism
- Deoxycytidine kinase
- Intracellular
- Good health and well-being